Podcasts about margolis center

In this edition of Pophealth Week, we welcome David Muhlestein, PhD, JD, an influential figure in healthcare research and entrepreneurship with a passion for reforming healthcare payment and delivery systems. Our conversation centers on the advancement and, potentially, the maturation of the market towards value-based care models, spanning from HMOs to ACOs and including a variety of initiatives in both public (Medicare, Medicaid) and private sectors. David offers his expertise to define the landscape, shedding light on the hurdles and prospects facing practitioners in this evolving space. A proclaimed data and policy enthusiast, David is renowned for his contributions to discussions on value-based care and the progression of healthcare systems. His roles include Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University and Adjunct Assistant Professor at The Ohio State University College of Public Health. His previous positions have seen him as the Chief Research and Innovation Officer for Health Management Associates, and Chief Strategy and Chief Research Officer for Leavitt Partners, along with a tenure as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at Dartmouth College. David's academic credentials are comprehensive, holding a PhD in Health Services Management and Policy, JD, MHA, and MS from The Ohio State University, alongside a BA from Brigham Young University. Dive into a thought-provoking discussion on the future of healthcare with us!

Hey, thanks so much to kwebs14 for your super nice review on iTunes the other day. Kwebs wrote: [I have] learned so much, shared so many episodes with colleagues, clients … and gained so much value from regularly listening to [Relentless Health Value]. … Thank you … for providing the platform for so many that believe that we can consistently do better in healthcare. Thanks much for writing this. I think our Relentless Tribe is a unique group, and every day of every week I admire your willingness to hear some things that might be pretty hard to hear because they may hit pretty close to home. Dr. Benjamin Schwartz was talking about the podcast on LinkedIn the other day, and he said he doesn't always agree with guests or the discussion but he always learns something and each episode stimulates and challenges his thoughts and opinions. Yes … to all of this. This is our goal in a nutshell: to help those who want to do better in healthcare to have the insight, the information, the other side of the story, the differing opinion, whatever you need to conceive of the action that you want to take. So, thank you so much to everybody who listens. You are the ones who are going to make a difference, and I thank you from the bottom of my heart for doing what you do every day for patients and communities. Alright, so in this healthcare podcast, we are going to answer an FAQ—a listener question I have gotten a lot lately in various forms. Let me common denominator the inquiry: What does it mean to be clinically integrated, and how does a provider organization/practice/CIN (clinically integrated network) know if they are actually clinically integrated or not? Also, the corollary to this question, which is how do CINs—or anybody, really—know if they are clinically integrated enough to start thinking about taking on downside risk? I asked David Muhlestein this question, and then we talk about his answer for 25 minutes. So, like most things in healthcare, it is filled with nuance; but if I was going to oversimplify his answer in one sentence, it's this: Did the practice change how they are practicing medicine in order to drive predetermined outcomes? This is the litmus test for whether care is integrated. Did practice patterns change within participating entities from whatever they were before to a new way of working? Did the team(s) reorient with a goal to attain some documented patient outcomes, be those outcomes patient satisfaction and/or clinical endpoints and/or functional endpoints? If no sort of fundamental change happened, probably it's a no on the clinical integration question. Another litmus test question I've also heard is this: Is the practice looking to get paid more for successes they've already had in upside risk arrangements with kind of little or no desire to transform the practice into a new practice model? If yes, then again, it's gonna be a no on the clinical integration question. The thing is with all of this … well, let me quote Dr. John Lee, who said this pretty succinctly on LinkedIn recently. He said, “Downside risk fundamentally changes how you have to think as a physician and how you manage your patient cohort. You start thinking about team-based care and using analytics.” Yes … interesting. The point Dr. Lee is making — which is kind of inferred, actually, in the listener questions, so let me just state the obvious, which is so obvious it could easily be overlooked — if you are able to take on downside risk and succeed, you're probably clinically integrated. If you're not, you probably aren't. Said another way (this might get a little chicken and egg-y), do you clinically integrate so that you can get the kind of risk-based contracts that enabled Iora, for example, to represent 5% of One Medical's patient base and 50% of its revenue? I have heard similar profitability stories about ChenMed and Oak Street. They all have capitated downside risk accountable care contracts. And have you seen what some of their leadership teams are minting? Obviously, the capitated downside risk when you're integrated gig can be highly profitable. But ... seems like also the community and outcomes are kind of great. Are they doing well by doing good? I'll grant you I might be convinced based on what I've seen. Galileo is another one. Cityblock. But the fundamental question is, do you integrate first and then go after the contracts? Or is it best to wait until there's a decent accountable opportunity on offer and then, sufficiently incented, change the practice? I do not know. I do know, however, what Scott Conard, MD, said in episode 391. I will poorly paraphrase. He said that if better patient outcomes are desired, there must be clinical integration and practice pattern changes. He said his practice went ahead and instituted these changes to improve patient care and did so within a pretty full-on FFS (fee-for-service) environment. My conclusion with all of this? It takes strong leadership with team-building skills and a strong family/community-centric mission to pull off a successful foray into accountable care with downside risk. These same talented and mission-driven leaders probably could manage to improve patient care and lower costs in an FFS environment as well. The converse of this is also likely true: Weak and ineffectual leaders can make a quadruple nothing burger mess in even the best VBC (value-based care) model. Yes … lots to unpack there. I am interested in your thoughts. In this episode, as mentioned, I am speaking with David Muhlestein, who is the chief research and innovation officer with Health Management Associates, or HMA. He has spent the past decade-plus studying ACOs (accountable care organizations) and value-based care, trying to understand what works, what doesn't, and how you change the business models to be successful under these new models of payment. Here is a short version of David's advice to clinically integrate and be ready for downside risk: ·       Step 1: Understand where you are—this includes doing a very clear-eyed self-assessment. ·       Step 2: Assess the needs of your patient population and focus on things where your capacity meets the needs of the population that you serve in the most impactful way. ·       Step 3: Take the outcome of step 2—which is basically whatcha gonna do to fix the most consequential problems that your patients have—and identify the processes by which you will do this. ·       Step 4: Do not boil the ocean. Start with a subset of patients and figure out the exact plan to do better to manage that population—easier said than done, of course. (Betsy Seals, by the way said something along these exact same lines in the shows giving advice to Medicare Advantage plans. And Karen Root [EP381] also alludes to something similar as she talks about how to socialize innovation. So clearly, this advice can be universalized.) You can learn more by emailing David at dmuhlestein@healthmanagement.com and by connecting with him on LinkedIn.     David Muhlestein, PhD, JD, is chief research and innovation officer for Health Management Associates (HMA). He is responsible for the firm's self-directed research and supports strategic planning and innovation. David's research and expertise center on healthcare payment and delivery transformation, understanding healthcare markets, and evaluating how the broader healthcare system is changing. He is a self-identified data nerd and regularly speaks and writes about healthcare system evolution. David joined HMA via its acquisition of Leavitt Partners in 2021, where he was the chief strategy and chief research officer. Additionally, David is a visiting policy fellow at the Margolis Center for Health Policy at Duke University, adjunct assistant professor at The Ohio State University College of Public Health, and a visiting fellow at the Accountable Care Learning Collaborative. He previously served as adjunct assistant professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College. David earned his PhD in health services management and policy, JD, MHA, and MS from The Ohio State University and a BA from Brigham Young University.   07:57 What does it mean to be clinically integrated? 10:23 How does changing practice patterns count as becoming clinically integrated? 11:11 How do you change the delivery of care to get better outcomes? 12:05 What does it mean to see better outcomes when becoming clinically integrated? 14:46 EP176 with Dr. Robert Pearl. 17:42 “Their structure is dictating what they are going to prioritize.” 19:02 “How do you care for the patients that have yet to come and see you?” 20:16 EP391 with Scott Conard, MD. 22:38 “When you're integrated, you realize you're not alone.” 25:50 Why does clinically integrating require a significant mindset change? 28:55 What does this country need to do from a policy perspective for this change? 30:24 EP326 with Rishi Wadhera, MD, MPP.   You can learn more by emailing David at dmuhlestein@healthmanagement.com and by connecting with him on LinkedIn.   @DavidMuhlestein of @HMAConsultants discusses #integratedcare on our #healthcarepodcast. #healthcare #podcast #digitalhealth   Recent past interviews: Click a guest's name for their latest RHV episode! Nikhil Krishnan (Encore! EP355), Emily Kagan Trenchard, Dr Scott Conard, Gloria Sachdev and Chris Skisak, Mike Thompson, Dr Rishi Wadhera (Encore! EP326), Ge Bai (Encore! EP356), Dave Dierk and Stacey Richter (INBW37), Merrill Goozner, Betsy Seals (EP387), Stacey Richter (INBW36), Dr Eric Bricker (Encore! EP351), Al Lewis, Dan Mendelson, Wendell Potter, Nick Stefanizzi, Brian Klepper (Encore! EP335), Dr Aaron Mitchell (EP382), Karen Root, Mark Miller, AJ Loiacono, Josh LaRosa, Stacey Richter (INBW35), Rebecca Etz (Encore! EP295), Olivia Webb (Encore! EP337), Mike Baldzicki, Lisa Bari, Betsy Seals (EP375)      

Hosts Gregg Masters and Fred Goldstein's guests are former CMS Administrator & FDA Commissioner and current Director and Robert J Margolis MD professor of business, medicine and health policy at the Margolis Center for Health Policy at Duke University, Mark McClellan MD PhD, and Paula Eichenbrenner, Executive Director of the AMCP Foundation. They discuss his receipt and significance of the Steven G Avey Award and the upside role of pharmacists in value based healthcare. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this healthcare podcast, we're gonna zoom out and look at the entire healthcare industry. I am very confident that you know a lot about the healthcare industry and its basic stats. It's huge. The healthcare industry is approaching the $4 trillion mark, and it employs more people than any other industry in 47 states. Think about that momentarily. More people work in healthcare than in any other industry in every state except for Wisconsin, Indiana, and Nevada. We could get into (but we won't) how many of the gigantic, consolidated incumbents in the healthcare industry are either for-profits sporting very happy shareholders or investors. Then, of course, we have our “nonprofits”—especially mega-nonprofit health systems—who enjoy some pretty healthy margins while, at the same time, these health systems in general offer up some fairly embarrassing levels of charity care considering the amount of taxes they deprive their communities of. You also are probably eminently familiar with various ways that have been cited to transform the industry. So, the usual suspects here are, of course, changing incentives—offering true value-based care contracts, for example—and then the whole creative destruction angle, wherein upstarts come in with far superior products and services, à la the whole Kodak case study or what happened to Sears and Kmart. Maybe this will happen in healthcare. Other ideas to transform the healthcare industry include employers harnessing the latent power that they have in some markets and then, of course, getting rid of middle people, for sure. Or we could go single payer, of course. That's another suggestion/solution. Today's conversation is a rather holistic look at all of this. I dig into this with David Muhlestein, who is chief research and innovation officer at Health Management Association (HMA). And when I say dig in, I mean dig in. David made some very intriguing points that I had not heard before, actually—and I've heard a lot in my time, so that's saying something. I'm gonna tick off a couple of them, but I don't do them justice. So, you'll need to listen to David explain them and give context. First off, what's the problem with healthcare being a $4 trillion industry in this country—I mean, almost 20% of GDP—and employing more people than any other industry in 47 of our 50 states? There are other big sectors in our economy, after all, that get lots of love. Why is big healthcare “bad” and these other sectors “good” in economic terms when we talk about employment? That's one thing I wanted to know. And David made a point that may be self-evident for some but is worth reiterating in all cases. The government pays for roughly half of healthcare, and from a consumer or just American standpoint, it kind of sucks. I mean, I don't see many Insta selfies of someone rocking their brand-new insurance premium. Dollars going to healthcare or health insurance are not going to consumer goods. And that matters economically as well as retail therapy. For all you econ geeks out there, this industry offers no marginal utility. Here's a second interesting point: Just changing incentives might not be enough. Organizations downstream and upstream need to be on board with the spirit and objective of the incentive change. If they are not, then it's game on for every CFO and their revenue cycle managers to finagle how to find the loophole that enables revenue maximization. Revenue maximization. Period. Revenue. The end. Which brings me to another interesting point: Boards of directors, CEOs, people with fiduciary responsibility … they need to know thyself and consider their actual customer. Spoiler alert: 99% of the time, that actual customer is not patients, no matter what is printed in big letters on the front door. No change can really happen unless those who serve in the upper echelons of these businesses get really real about where their bread is buttered. Organizations are built to serve their customer, after all. So, if a patient isn't identified as a customer, the organization at its very core is gonna have a lot of difficulty serving the patient. So, now what? If I want my organization to move forward in a way that is more patient-centric and less financially toxic, say, what to do? Here's thoughts after chatting with David Muhlestein. Four main steps: As I just said, you gotta get your current state unemotionally understood. For reals, who is the organization built to serve? So, first step is being introspective in the harsh light of day. Consider the timeline of your existential demise. Ha ha, this show is so uplifting. But unless organizations really think out 5 years, 10 years, 25 years and really internalize the existential threat, it's going to be hard to motivate change. I see this all the time. So do you. Inertia is real. Nobody does anything until they absolutely have to. Sidebar: But if you need an eventual demise to bring up at your next strategy meeting, I just saw a paper come out saying that by 2030, cost-related nonadherence could become a leading cause of death in the United States, surpassing diabetes, influenza, pneumonia, and kidney disease. This is as per a study by the nonprofit West Health Policy Center and Xcenda. Nonadherence … what does that mean? It means the patient is not doing their treatment. They are not going to the doctor or getting medical care or not taking their drugs. Meaning no one is making money off of all of those patients, especially when they're dead. This is where the rubber meets all of those excess profits everybody is reaping in the short term. I hope that was helpful for anybody trying to motivate change today.   Consider what legacy we want to leave behind. Do we all want to wait until we're forced to change to do so? Is this the healthcare system we want to leave behind to children and grandchildren? I mean, anybody who's got a loved one in the hospital with anything complex, fighting for their own patient records, on the phone for hours a day with insurance carriers while care is delayed with possibly devastating consequences, the family having to coordinate care and cross their fingers and pray they don't get a ridiculous bill for services that may or may not have been rendered and then use retirement savings to pay for them … if anyone is not looking to be a party to all of this, then let's think about our strategy moving forward and how it will change to meet the future we want to see. On to the evolve and change approaches: How exactly do you think about doing that? According to David Muhlestein, you can repair your current organization or remodel or rebuild. It sounds daunting, but as Dr. Eric Bricker said on our recent interview together (EP351) and as others have said as well, this is already happening in some regions across the country. There are pockets with real transformation. These changes are on the edges right now, but they're showing that this can and is possible.   You can learn more at healthmanagement.com.   David Muhlestein, PhD, JD, is chief research and innovation officer for Health Management Associates (HMA). He is responsible for the firm's self-directed research and supports strategic planning and innovation. David's research and expertise center on healthcare payment and delivery transformation, understanding healthcare markets, and evaluating how the broader healthcare system is changing. He is a self-identified data nerd and regularly speaks and writes about healthcare system evolution. David joined HMA via its acquisition of Leavitt Partners in 2021, where he was the chief strategy and chief research officer. Additionally, David is a visiting policy fellow at the Margolis Center for Health Policy at Duke University, adjunct assistant professor at The Ohio State University College of Public Health, and a visiting fellow at the Accountable Care Learning Collaborative. He previously served as adjunct assistant professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College. David earned his PhD in health services management and policy, JD, MHA, and MS from The Ohio State University and a BA from Brigham Young University. 07:38 Is it an issue for the healthcare industry that it is one of the largest employers in the country? 08:42 “I think that we need to figure out what is an appropriate amount to spend on healthcare and get to that level.” 09:01 How do we not decrease the amount of healthcare we're receiving while paying less for that healthcare? 10:11 What are the two ways we can look at decreasing healthcare spend? 15:39 “I think that a regional approach may happen.” 16:56 “When somebody takes less, others are going to follow them.” 17:33 Who is really paying in our current healthcare system? 19:47 “Any sort of a model that you start with influences everything else that you do.” 20:09 What's the common challenge David Muhlestein sees in value-based care systems? 23:21 “There are countless things that you can do to improve the current system today.” 27:25 What are the three options for building up better healthcare? 28:19 David's advice for healthcare executives. 33:22 “To really lower the total cost of … healthcare, it's a 30-year process.” You can learn more at healthmanagement.com.   @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth Is it an issue for the healthcare industry that it is one of the largest employers in the country? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think that we need to figure out what is an appropriate amount to spend on healthcare and get to that level.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth How do we not decrease the amount of healthcare we're receiving while paying less for that healthcare? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth What are the two ways we can look at decreasing healthcare spend? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think that a regional approach may happen.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “When somebody takes less, others are going to follow them.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth Who is really paying in our current healthcare system? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “Any sort of a model that you start with influences everything else that you do.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth What's the common challenge David Muhlestein sees in value-based care systems? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “There are countless things that you can do to improve the current system today.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “To really lower the total cost of … healthcare, it's a 30-year process.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth   Recent past interviews: Click a guest's name for their latest RHV episode! David Scheinker, Ali Ucar, Dr Carly Eckert, Jeb Dunkelberger (EP360), Dan O'Neill, Dr Wayne Jenkins, Liliana Petrova, Ge Bai, Nikhil Krishnan, Shawn Rhodes, Pramod John (EP353), Pramod John (EP352), Dr Eric Bricker, Katy Talento, Stacey Richter (INBW33), Stacey Richter (INBW32), Dr Steve Schutzer (Encore! EP294), Lisa Trumble, Jeb Dunkelberger, Dr Ian Tong, Mike Schneider, Peter Hayes, Paul Simms, Dr Steven Quimby, Dr David Carmouche (EP343), Christin Deacon, Gary Campbell, Kristin Begley  

The post Dr. Mark McClellan with the Duke-Margolis Center for Health Policy on the return to normalcy and reducing future COVID-19 outbreaks appeared first on NC Policy Watch.

It was a pleasure to talk with Susan Dentzer about the important work she is doing at the Robert J. Margolis Center for Health Policy at Duke University, the complexity of healthcare, and some of the challenges the healthcare system and leaders are facing today. Areas of focus for the Center have been health system transformation and specifically the transition from volume to value payment, biopharmaceuticals, medical products/devices, global innovation, and most recently health equity. Early in the interview Susan shares that before COVID, in her role as Senior Policy Fellow, she was interested in value-based payment and opportunities for delivery system transformation. More specifically she was interested in moving healthcare closer to the people leveraging technology rather than brining people into the healthcare environment. Spreading health into people and the communities to improve population health was another interest she held. Susan reveals one of the things that she has focused on more since COVID is telehealth, how it is being utilized now, what’s working and not working, and the path forward. During the episode we discuss the lessons being learned about telehealth, and the challenges yet to be overcome as we move past the COVID pandemic. We also talk about how telehealth is one-half of an interdependent relationship with the other half representing the ability to provide face-to-face and hands-on care when needed. We dialogue about how the tension between this pair shows up as resistance and fears. During the episode Susan shares her thoughts about the current healthcare system business model, which is deeply rooted in fee-for-service, and how it creates a barrier to healthcare delivery transformation. Susan was the editor of the book “Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care System” prepared by the Network for Excellence in Health Innovation(NEHI). She shares some background on the book and why it was written. Another topic we discussed during the interview is the need to transform education of future clinicians to prepare them for the delivery of care without walls, innovation, and the need for ongoing continuing education to meet healthcare needs in an ever-changing reality. If you are interested in being involved in policy or advocacy, Susan has some suggestions on where to start. She also encourages you to never underestimate what you know and the experiences you have had because you will be shocked at what others don’t know or what they don’t understand about current healthcare realities. You probably already realize this is an informative and important dialogue for anyone who is interested in healthcare transformation. Go ahead and listen now!Email us at questions@missinglogic.com if you have any questions, we may use your question on a future episode. If you found value in this episode, please leave us a review on Apple Podcasts! Our mission is to start “a movement” of leaders who address the chronic challenges in healthcare through a Polarity Thinking™ lens! If you're the kind of leader wants to help others, share this with your peers. Visit the show notes here for more: https://www.missinglogic.com/new-podcast

While a new administration addresses federal policy for the pandemic, vaccines, and more, the policy implementation remains largely with the states. Today’s guest is Hemi Tewarson, visiting fellow leading state health policy research at the Margolis Center for Health Policy at Duke University and former director of the National Governors Association Center for Best Practices Health Division. She discusses what changes to expect for healthcare policy, and how the states and industry can prepare. Today’s panel features Deanne Kasim, executive director of Healthcare Policy at Change Healthcare; Arien Malec, SVP of Research and Development at Change Healthcare; and Hemi Tewarson, senior policy fellow at the Margolis Center for Health Policy at Duke University. Here's what they discussed. The policy burden on states and how the federal government can help Policy issues put on hold during the pandemic that remain to be addressed The collision between surging demands and depleted state budgets The impact of predictable federal funding on health policy How to solve logistical challenges of vaccine distribution Overcoming public resistance to vaccination What’s next for telehealth policy How to institutionalize lessons learned from the pandemic Episode Resources Hemi Tewarson’s bio Deanne Kasim’s bio Arien Malec’s bio Margolis Center for Health Policy at Duke University Supporting an Equitable Distribution of COVID-19 Vaccines: Key Themes, Strategies, and Challenges Across State and Territorial COVID-19 Vaccination Plans Change Healthcare Government Affairs Change Healthcare Industry Insights COVID-19 Updates and Resources COVID-19 Updates Newsletter Change Healthcare Insights Newsletter Show Resources SUBSCRIBE to the podcast using any podcatcher or RSS reader Suggest or become a guest Contact Change Healthcare

Every state in the country is involved in distributing and administering the two COVID-19 vaccines now approved for use by the US. Food and Drug Administration. Each state is working with a plan that it created in consultation with the federal government. On this podcast we discuss how those plans were created, how they’ve had to change as the pandemic has progressed and what lies ahead. Our guests are Hemi Tewarson, an expert in state plans to distribute the COVID-19 vaccines. She is a visiting senior policy fellow at the Margolis Center for Health policy at Duke University. As a health policy expert, she has studied the state vaccine plans and discusses how those are working, changes in federal guidance and when everyone will have access to the vaccine. Our other guest is Tahra Johnson, a policy expert at NCSL. Tahra discusses state legislative action related to vaccine plans and how legislators can get involved in the planning process.       Resources COVID-19 Vaccination Program- Interim Playbook, Centers for Disease Control and Prevention State Action on Coronavirus (COVID-19), NCSL COVID-19 Legislation Database "First COVID-19 Vaccine Administered in the U.S.," State Legislatures magazine Framework for Equitable Allocation of COVID-19 Vaccine, National Academy of Medicine State Health Action on Coronavirus (COVID-19)

The COVID-19 pandemic has highlighted the downside of America's fee-for-service reimbursement system. Take a listen as Don Crane, APG President and CEO, talks with Mark McClellan, MD, former head of CMS, FDA, and current Professor at the Margolis Center for Health Policy at Duke University, about where he sees things headed with value-based care. Dr. McClellan says the pandemic provides a real opportunity that we haven’t had before to engage the public around the value of care models that are centered on them and are flexible enough to deliver the best care they need to stay well.

-- This episode’s Community Champion Sponsor is Ensemble Health Partners. To learn more about their inspiring work: https://www.ensemblehp.com/ (CLICK HERE) -- For months, all of us have been personally or professionally battling COVID-19, or both.  This global public health crisis has inflicted terrible physical, mental, emotional, financial, and spiritual strain on billions of people around the world.   Yet, during these challenging times, another crippling disease has taken root across our nation- we are now facing an infodemic that is, unfortunately, impacting some of our friends, colleagues, and loved ones.  To confront the issue of disinformation during this pandemic, I asked Susan Dentzer to join us to shed light on this critically important issue.  For ten years, Susan was the former on-air Health Correspondent for the PBS NewsHour. Additionally, she was the editor-in-chief of the policy journal Health Affairs and is currently a Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University.  I’m grateful to have Susan on our podcast to confront the infodemic scourge plaguing many of our communities and the opportunity to learn from her how we can work together to move the health of the nation forward. Work that must be based on facts and science. Let’s go!  Episode Highlights: Susan’s storied career, including PBS NewsHour On-Air Health Correspondent Uncertainty of facts during the pandemic Politics and COVID-19 Impact of misinformation to our society, nation, and the world Susan’s current work with the Robert J Margolis Center for Health Policy at Duke University About our Guest:  Susan Dentzer is Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University.  Based in Washington, DC, where the center’s research team is located, she focuses on the COVID-19 pandemic response; health system transformation, such as through telehealth; biopharmaceutical policy; health care issues in the 2020 elections,  and other key health policy issues.   Dentzer is one of the nation's most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare.  She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care, available on Amazon.com. From March 2016 to February 2018, Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, a nonprofit, nonpartisan organization then composed of more than 80 stakeholder organizations from across all key sectors of health and health care.  From 2013 to 2016, she was a senior policy adviser to the Robert Wood Johnson Foundation, the nation’s largest philanthropy focused on health and health care in the United States, and before that, was the editor-in-chief of the policy journal Health Affairs. From 1998 to 2008, she was the on-air Health Correspondent for the PBS NewsHour. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation.  Dentzer is an elected member of the National Academy of Medicine (formerly the Institute of Medicine) and also serves on the Board on Population Health and Public Health Practice of the National Academies of Science, Medicine, and Engineering. She is an elected member of the Council on Foreign Relations; a fellow of the National Academy of Social Insurance; and a fellow of the Hastings Center, a nonpartisan bioethics research institute. She is also a member of the Board of Directors of the International Rescue Committee, a leading global humanitarian organization; a member of the board of directors of... Support this podcast

Can Republicans and Democrats work together to help the chronic disease community? Former FDA Commissioner Dr. Mark McClellan predicts what healthcare challenges may benefit from bipartisan support in the new year. Plus, he offers his view on the future of the FDA. Terry and Dr. Bob review President-elect Biden’s cabinet picks, as Kate visits with patient advocate Kristina Wolfe about her fight for patient rights and handling advocacy burnout. Guest:Mark McClellan, MD, PhDDirector, Margolis Center for Health Policy at Duke University Mark McClellan, MD, PhD, is Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence, and more effective drug and device innovation. Dr. McClellan is at the center of the nation’s efforts to combat the pandemic, and is the author of a roadmap that details the steps needed for a comprehensive COVID-19 response. He is the former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. Dr. McClellan is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Arsenal Capital Group, Blackstone Life Sciences, and MITRE.Hosts:Terry Wilcox, Executive Director, Patients RisingDr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.Kate Pecora, Field Correspondent Links:Mark McClellan, MD, PhDDeploying Big Data to Determine How Well Vaccines WorkKristina WolfePatients Rising Concierge Need help?The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.orgHave a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?Drop us a line: podcast@patientsrising.orgThe views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.

This episode features Susan Dentzer, Senior Policy Fellow at Duke University - Robert J. Margolis Center for Health Policy. Here, she discusses what she’s seeing in current healthcare trends, the possibility of a public option for healthcare post-2020 election, and more.

On this week’s episode of the Healthcare Happy Hour we are taking a break from the crazy politics in Washington to focus on potential data-driven solutions to lower healthcare costs. Susan Dentzer, Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University and host of Optum’s new health policy podcast Until It’s Fixed joins us to discuss what’s working and what isn’t working in our healthcare system and how we can lower costs through untangling administrative complexity.

Trust the WoMed to provide you with your weekly dose of healthcare knowledge! This week’s guest is Susan Dentzer, highly regarded health policy expert and Senior Policy Fellow at the Robert J. Margolis Center for Health Policy at Duke University whose experience reporting on healthcare spans decades. She is also the soon to be host of Optum’s podcast, Until It’s Fixed. In this episode, Susan drops some major knowledge bombs as she and host D discuss the major disconnect between what clinicians and patients experience on the ground versus the decisions made by policy makers. Check out the Kaiser Family Foundation’s website at kff.org for a trusted and accessible source of news on health policy issues and tune in as Susan Dentzer hosts Optum’s new podcast Until It’s Fixed coming out October 6! Be sure to subscribe, rate and review, and follow us on Instagram and Twitter @TheWoMed! Remember to submit your weekly Nurse D Energy moments to D on Instagram - we love reading and sharing them! Thank you to our amazing sponsors! Check out these deals for our listeners: DAILY HARVEST- Go to dailyharvest.com and enter promo code “womed” to get $25 off your first box! Learn more about your ad choices. Visit megaphone.fm/adchoices

The Interface - Around here we say that The Interface comes out Monday through Thursday, and on particularly newsy Fridays. Well, today was a particularly newsy https://www.getrevue.co/profile/caseynewton/archive/239567 I wrote about some of the limitations in using the Bluetooth chip in your smartphone to track the spread of COVID-19had the details in The VergeThe new systemwhitepapersstart with this explainer from my colleague Nicole Westmanthe privacy design of the Apple/Google system is quite cleverhas some quibbles, thoughAdi Robertson details the process herein a paper this week from Duke University’s Margolis Center for Health Policyaccording to a March paper in Science

In this episode of Fireside Chat, I sat down with Dr. Mark McClellan, Director and Professor, Duke’s Margolis Center and former FDA Commissioner and CMS Administrator to talk about containment of the coronavirus (COVID-19) pandemic and response from the federal government and the private sector. Please note: The number of COVID-19 cases and the situation referenced in this episode were based on reported data at the time of the interview and are subject to change.

A discussion on how to deliver healthcare at a lower cost for individuals, businesses, and everybody paying the bill

Vital Transformation launches its new series of Better Science, Better Health podcasts focused on the challenges and opportunities of new medicines. With the increasing focus on drug pricing in the US Congress and Senate, and with the Trump Administration's proposals for international reference pricing on therapies covered under Medicare Part B, Vital Transformation shares the insights of Dr. Mark McClellan, one of the world's most important thought leaders in value-based healthcare. Mark McClellan is the founding Director of the Duke-Margolis Center for Health Policy at Duke University. He is a world-renowned physician and economist who has researched outcomes-based reimbursement and real-world evidence evaluation models for new therapies. Dr McClellan was both the former administrator of the Centers for Medicare & Medicaid Services and Commissioner of the FDA. He was a Senior Fellow in Economic Studies at the Brookings Institution, where he was the Director of the Health Care Innovation and Value Initiatives.

Tuesday, October 3rd our special guest on This Week in Accountable Care Leavitt Partners, Chief Research Officer David Muhlestein, PhD, JD joins Andre Berger, MD and Alex Foxman, MD for a 'pulse check' on the accountable care industry including key insights from a recent publication: Medicare Alternative Payment Models: Not Every Provider Has a Path Forward. More about David: David Muhlestein, PhD, JD, is Chief Research Officer based in Washington, DC.  He directs the study of accountable care organizations through the LP Center for Accountable Care Intelligence and leads the firm’s quantitative evaluation of health care markets. He is an expert in using policy analysis, predictive modeling, and applied analytics to understand the evolving health care landscape. David also serves as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College, is a Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University, and is a Visiting Fellow at the Accountable Care Learning Collaborative.  In these roles he conducts research to translate learnings of high-performing organizations for the benefit of the broader health care system. Join National ACO co-founders Drs. Andre Berger and Alex Foxman for an informative exploration!

Tuesday, October 3rd, Leavitt Partners, Chief Research Officer David Muhlestein, PhD, JD joins Andre Berger, MD and Alex Foxman, MD for a 'pulse check' on the accountable care industry including key insights from a recent publication: Medicare Alternative Payment Models: Not Every Provider Has a Path Forward. More about David: David Muhlestein, PhD, JD, is Chief Research Officer based in Washington, DC.  He directs the study of accountable care organizations through the LP Center for Accountable Care Intelligence and leads the firm’s quantitative evaluation of health care markets. He is an expert in using policy analysis, predictive modeling, and applied analytics to understand the evolving health care landscape. David also serves as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College, is a Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University, and is a Visiting Fellow at the Accountable Care Learning Collaborative.  In these roles he conducts research to translate learnings of high-performing organizations for the benefit of the broader health care system. Join us!

Duke-Margolis Center for Health Policy Director Mark McClellan talks about the February 9 launch of the center, work on value-based payments, and thoughts on “smarter regulation” and the FDA commissioner job.

Health insurance premiums for individuals dropped by 10 percent during the first year of Obamacare. What does that number say about whether or not the Affordable Care Act is working? Don Taylor and Michael Cannon debate that question on this episode of Zeroing In, with host Aaron Chatterji. Taylor is a professor at Duke University's Sanford School of Public Policy and the Margolis Center for Health Policy. Cannon is the director of health policy studies at the libertarian Cato Institute in Washington, D.C. Aaron Chatterji is an associate professor at Duke's Fuqua School of Business and Sanford School of Public Policy.